Literature DB >> 19513038

US regulator wades into stem cell therapies for heart disease.

Randy Osborne.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19513038     DOI： 10.1038/nbt0609-496c

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.

Authors:  A A Kocher; M D Schuster; M J Szabolcs; S Takuma; D Burkhoff; J Wang; S Homma; N M Edwards; S Itescu
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440
  1 in total
  1 in total

1.  Regulation of stem cell-based therapies in Canada: current issues and concerns.

Authors:  Barbara von Tigerstrom; Thu Minh Nguyen; Bartha Maria Knoppers
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.